NexThera Co., Ltd.
PrivateLast Round
Strategic
Mar 26, 2024
Total Funding Raised
$12.5M
Company Overview
NexThera Co., Ltd. is a biotechnology company that develops recombinant protein-based platform technologies for novel therapeutics and drug delivery systems, focusing on treatments for wet age-related macular degeneration and thrombocytopenia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NexThera Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NexThera Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 26, 2024 | ||||
| Series A Extension | Dec 11, 2023 | ||||
| Series A | Jan 8, 2022 |
NexThera Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A |
| KB Investment | Series A Extension |
| Ministry of Science and ICT of South Korea | Grant |
| Woori Venture Partners Co., Ltd. | Series A Extension |
| KB Securities | Series A, Series A Extension |
| Daol Investment | Series A |
| BNK Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2024
$2.23M raised from BMI Korea and EyeGene Inc.
- Dec 11, 2023
$4.2M round led by Fast Ventures and Solidus Investment.
NexThera Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NexThera Co., Ltd.'s valuation, stock price, and market status.